MOREPENLAB Share Price Today - Morepen Laboratories on NSE/BSE

Market Cap

2,583.05 Cr

EPS

2.20

PE Ratio

29.49

Dividend Yield

0.40 %

Industry

Healthcare

52 Week High

100.90

52 Week Low

42.00

PB Ratio

2.36

Debt to Equity

0.03

Sector

Pharmaceuticals

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Company News

View All News

Morepen Laboratories Reports Q1 2025 Results, Sets Dividend Record Date, and Approves Leadership Changes

2 days ago

Morepen Laboratories announced its unaudited financial results for Q1 2025, showing consolidated net profit of Rs 1,074.83 lakhs compared to Rs 3,616.79 lakhs in the same quarter last year. Standalone net profit was Rs 806.12 lakhs versus Rs 3,504.96 lakhs in Q1 2024. The company set August 30, 2025 as the record date for final dividend distribution for FY 2025, pending shareholder approval at the 40th AGM. The board approved the re-appointment of Sanjay Suri as Whole-Time Director for three years from August 13, 2025 to August 12, 2028, and appointed M/s. PD and Associates as Secretarial Auditor for five years from FY 2025-26 to 2029-30. The company also approved extension of time for transferring its Medical Devices Business to subsidiary Morepen Medipath Limited. Additionally, the company's shareholding in Dr. Morepen Limited decreased from 80% to 19.94% following equity transactions. The 40th AGM is scheduled for September 6, 2025 via video conferencing.

Morepen Laboratories Reports Decline in Q1 Financial Performance

2 days ago

Morepen Laboratories reported Q1 revenue of 4.2 billion rupees, down from 4.55 billion rupees in the same period last year. The company's consolidated net profit fell significantly to 114 million rupees compared to 362 million rupees year-over-year. EBITDA declined to 242 million rupees from 516 million rupees, while EBITDA margin compressed to 5.68% from 11.34% in the previous year's corresponding quarter.

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,586.90	#1 3,80,750.47	33.44	#1 54,729.00	9.71	#1 10,980	-19.84	31.56
Divis Laboratories	5,914.50	1,57,011.39	70.60	9,712.00	18.67	2,191	26.74	22.93
Torrent Pharmaceuticals	3,573.20	1,20,933.32	60.28	11,539.40	6.99	1,911	19.91	54.53
Cipla	1,485.80	1,20,009.23	22.34	28,409.50	7.12	5,291	9.88	44.32
Mankind Pharma	2,467.10	1,01,824.31	55.50	12,744.20	#1 20.90	2,007	-18.14	41.66
Dr Reddys Laboratories	1,211.40	1,01,099.94	#1 17.64	33,741.20	16.73	5,725	1.26	37.46
Zydus Life Science	936.15	94,198.59	20.47	23,511.00	13.82	4,615	-0.19	39.45
Lupin	1,918.00	87,594.19	24.03	22,909.50	13.74	3,306	#1 51.64	48.64
Abbott	32,845.00	69,793.33	49.21	6,684.70	10.80	1,414	27.83	43.93
Aurobindo Pharma	1,042.10	60,525.34	18.48	31,378.10	17.55	3,366	-10.24	31.42

Automatic Screeners on ScanX

Forecast

Actual

Growth Rate

Revenue Growth

19.72 %

Net Income Growth

149.61 %

Cash Flow Change

180.48 %

ROE

121.79 %

ROCE

113.54 %

EBITDA Margin (Avg.)

68.27 %

Quarterly Financial Results

Quarterly Financials	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024	Mar 2025	Jun 2025
Revenue	132	151	156	172	164	174	215	220	203	216	235	208	259	340	310	291	388	398	399	372	303	404	350	367	404	425	449	427	459	443	458	471	430
Expenses	121	130	137	154	152	157	195	197	184	198	215	188	231	305	278	256	343	353	364	350	288	374	328	348	375	388	394	375	404	394	417	424	401
EBITDA	11	20	19	18	12	17	19	23	20	18	20	21	28	36	33	35	45	45	35	22	16	30	22	19	29	37	55	53	55	49	42	47	29
Operating Profit %	7 %	13 %	12 %	10 %	7 %	10 %	8 %	10 %	10 %	7 %	7 %	9 %	10 %	9 %	10 %	11 %	11 %	11 %	8 %	5 %	5 %	7 %	6 %	4 %	7 %	8 %	11 %	11 %	11 %	10 %	8 %	9 %	6 %
Depreciation	9	8	8	10	9	10	10	11	12	8	9	9	8	8	8	7	7	7	7	7	7	7	7	7	8	8	8	10	6	2	5	17	9
Interest	1	1	1	1	0	0	0	1	0	0	1	1	0	0	1	-0	0	-9	1	1	0	1	1	1	0	1	2	1	1	1	1	5	4
Profit Before Tax	1	11	10	7	3	7	9	11	8	9	11	11	20	28	24	28	39	47	27	14	8	22	14	11	21	29	44	42	48	46	35	26	16
Tax	0	0	0	0	0	-0	0	0	0	5	0	0	0	0	0	1	8	10	6	2	3	7	5	3	6	7	12	14	12	11	9	5	4
Net Profit	1	11	10	7	3	7	9	11	8	4	11	11	19	27	24	27	31	37	22	12	6	16	9	8	15	21	32	29	36	35	27	20	11
EPS in ₹	0.03	0.25	0.23	0.15	0.05	0.16	0.20	0.23	0.17	0.09	0.24	0.25	0.43	0.60	0.53	0.59	0.68	0.83	0.48	0.27	0.12	0.33	0.15	0.16	0.29	0.42	0.63	0.54	0.71	0.65	0.49	0.35	0.20

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	489	524	538	586	615	664	858	1,070	1,111	1,293	1,778
Fixed Assets	323	297	272	264	236	216	225	252	267	307	442
Current Assets	115	157	192	243	300	372	527	734	756	889	1,159
Capital Work in Progress	0	0	0	0	0	0	2	14	17	25	28
Investments	0	0	0	0	0	1	1	0	0	1	300
Other Assets	167	227	267	321	379	446	631	804	827	960	0
Total Liabilities	489	524	538	586	615	664	858	1,070	1,111	1,293	1,778
Current Liabilities	128	167	325	340	339	351	404	457	321	402	501
Non Current Liabilities	74	58	18	20	23	28	30	36	37	44	91
Total Equity	287	300	196	226	253	284	424	578	752	847	1,156
Reserve & Surplus	78	91	106	136	163	194	291	457	651	745	1,047
Share Capital	210	210	90	90	90	90	90	96	102	102	110

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	-0	-5	3	-1	4	4	28	-26	6	-5
Investing Activities	-32	-27	-14	-27	-13	-13	-70	-32	-47	-83
Operating Activities	51	50	41	63	17	11	51	-60	-91	73
Financing Activities	-19	-27	-24	-38	-0	6	47	66	144	5

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	May 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Aug 2024	Sept 2024	Dec 2024	Mar 2025	Jun 2025
Promoter	34.54 %	34.54 %	34.54 %	34.54 %	38.38 %	36.74 %	36.74 %	38.22 %	38.22 %	38.22 %	38.22 %	38.22 %	38.22 %	38.22 %	38.22 %	35.65 %	35.65 %	35.65 %	35.65 %	35.65 %
FIIs	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	1.29 %	0.00 %	1.85 %	1.67 %	7.72 %	2.08 %	2.22 %	1.94 %	1.72 %
DIIs	2.89 %	2.03 %	1.26 %	1.16 %	1.07 %	4.07 %	4.07 %	3.60 %	3.74 %	2.93 %	2.33 %	2.28 %	2.00 %	2.15 %	2.15 %	2.90 %	1.70 %	1.64 %	1.67 %	1.51 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %
Public / Retail	42.97 %	43.89 %	44.82 %	45.18 %	42.50 %	40.88 %	40.91 %	43.63 %	44.03 %	45.04 %	45.49 %	45.56 %	44.44 %	45.03 %	45.22 %	41.89 %	48.16 %	48.35 %	48.76 %	49.35 %
Others	19.60 %	19.54 %	19.38 %	19.12 %	18.05 %	18.31 %	18.29 %	14.53 %	13.99 %	13.80 %	13.95 %	12.64 %	15.33 %	12.74 %	12.74 %	11.83 %	12.41 %	12.12 %	11.96 %	11.76 %
No of Share Holders	1,65,609	2,30,611	2,44,924	2,55,155	2,60,933	2,83,547	2,87,115	2,87,370	3,06,030	3,06,150	3,01,832	3,04,001	3,04,289	3,36,019	3,48,766	3,52,839	4,30,929	4,48,361	4,68,860	4,61,180

Show % Change

Corporate Action

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
06 Sept 2025	Annual General Meeting	NA	06 Sept 2025	56.56	47.14
30 Aug 2025	Dividend	₹ 0.20 /share	29 Aug 2025	56.23	47.14
06 Aug 2025	Quarterly Result Announcement	NA	06 Aug 2025	58.45	56.56
12 May 2025	Quarterly Result Announcement	NA	12 May 2025	59.26	56.23
10 Feb 2025	Extraordinary General Meeting	NA	10 Feb 2025	68.14	61.26
06 Feb 2025	Quarterly Result Announcement	NA	06 Feb 2025	64.67	66.62
11 Nov 2024	Quarterly Result Announcement	NA	11 Nov 2024	82.35	83.34
28 Sept 2024	Annual General Meeting	NA	28 Sept 2024	96.19	86.63
18 Mar 2024	Extraordinary General Meeting	NA	18 Mar 2024	53.30	41.96
02 Feb 2023	Change Of Name	NA	02 Feb 2023	28.05	28.05